logo
Select company
Select metric
76.79%Cash to Assets Ratio
VS
Market
96
Sector
87
Industry
80
History
25
$ 3.04Close
$ 1.41 - $ 15.24 52-Week Range
Ticker Information

Ticker

VIVS

Company Name

VIVOSIM LABS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VIVOSIM LABS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VIVS - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 11.98M$ 9.2M76.79%
3/31/2025$ 14.65M$ 11.46M78.19%
12/31/2024$ 3.84M$ 1.3M33.92%
9/30/2024$ 6.75M$ 3.32M49.11%
6/30/2024$ 9.47M$ 6.33M66.84%
3/31/2024$ 6.35M$ 3.04M47.94%
12/31/2023$ 8.88M$ 5.44M61.23%
9/30/2023$ 11.16M$ 7.76M69.53%
6/30/2023$ 14.76M$ 10.9M73.85%
3/31/2023$ 20.31M$ 15.44M76.03%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOSIM LABS INC's latest trailing twelve months (TTM) Cash to Assets stands at 85.53%.
  • Over the past 5 years, VIVOSIM LABS INC's average Cash to Assets has been 72.16%.
  • The median Cash to Assets for VIVOSIM LABS INC during this period was 76.41%
  • VIVOSIM LABS INC reached its highest Cash to Assets over the past 5 years at 94.48%.
  • The lowest Cash to Assets recorded by VIVOSIM LABS INC in the same timeframe 33.92%

VIVOSIM LABS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
AIM : AIM IMMUNOTECH INC 11.53%SILO : SILO PHARMA INC 65.14%GLTO : GALECTO INC 74.58%DRMA : DERMATA THERAPEUTICS INC 97.6%ADTX : ADITXT INC 1.65%OGEN : ORAGENICS INC 92.24%HCWB : HCW BIOLOGICS INC 8.44%SLRX : SALARIUS PHARMACEUTICALS INC 57.07%TOVX : THERIVA BIOLOGICS INC 33.95%REVB : REVELATION BIOSCIENCES INC 95.9%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for VIVOSIM LABS INC is calculated as follows: CashnEq [ $ 17.66M ] / Assets [ $ 20.64M ]
(=) Cash to Assets [ 85.53% ]

VIVS - Cash to Assets Ratio, Last 5 years

33.92%

Minimum

Dec 31, 2024

94.48%

Maximum

Sep 30, 2021

72.16%

Average

76.41%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%